Incidence of Liver Toxicity Associated with the Use of Flutamide in Prostate Cancer Patients
May 1992
in “
The American Journal of Medicine
”
Studysummary This study found that flutamide-induced liver toxicity in prostate cancer patients was very rare, occurring in only 0.18% of cases with clinical manifestations, and symptoms resolved after discontinuing the drug.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on amjmed.com →